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Abstract 
Inflammatory pseudotumour describes as a wide range of neoplastic and 
reactive lesions. One of the rare presentations of these tumors is found in the 
salpinx. This case report characterizes a thirty six year old woman with a 
history of left sided abdominal pain for a few months. Further examinations 
revealed that she had a complex cyst in her left salpinx. The patient had normal 
levels of tumor markers such as CA125, Alfa Fetoprotein (AFP), and Human 
Chorionic Gonadotropin (hCG), while other paraclinical test were in normal 
values Additionaly The patient underwent left salpingectomy by a 
gynecologist. The pathological diagnosis of the lesion was inflammatory 
myofibroblastic tumor (IMT). In immunohistochemistry the tumor stains was 
moderately positive in anaplastic lymphoma kinase (ALK) and also actin 
positive. Total resection of tumor was performed with no complications and 
remained disease free during follow up for 40 months. Although Inflammatory 
Myofibroblastic Tumor (IMT) is benign in nature, but in order to improve the 
prognosis, this tumor requires low intensity surgical treatment. 
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Introduction 
Inflammatory pseudotumors describe as a wide 
range of neoplastic and reactive lesions such as 
inflammatory myofibroblastic tumor (IMT) and 
inflammatory pseudotumors of spleen, lymph node 
and orbit [1]. Inflammatory myofibroblastic tumors 
arise in a variety of locations such as brain, bone, 
larynx, stomach, large intestine, small intestine, 
lung, liver, mediastinum, retroperitoneum and 
omentum which are mainly diagnosed in the first 
two decades of life [1-4]. 
In this case report, a very rare case of IMT 
arised from the salpinx was identified interestingly 
we could treat this tumor by a less aggressive 
method. 
 
Case Report 
The patient was a thirty six years old woman 
with a history of left sided abdominal pain for a few 
months before treatments. In her abdominal 
ultrasound examination she had a complex cyst with 
the diameter of 60×55×40 millimeters in left salpinx. 
The patient had normal levels of CA125, AFP and 
HCG and Para-clinical test. The patient underwent 
left salpingectomy by a gynecologist before referral 
to our center.  
The pathological diagnosis of the lesion was 
inflammatory myofibroblastic tumor. In 
immunohistochemistry (Figure 1) the tumor stains 
was moderately positive with anaplastic lymphoma 
kinase (ALK) and actin positive with. Based on the 
pathologic findings and according to related reports, 
we decided completing surgical treatment of the 
patient as a complete resection of the left adnexa. 
We recommend only a unilateral resection of left 
adnexa because of low malignant potential of this 
special tumor. Fortunately in second look surgery no 
residual tumor was detected in left adnexa. In post 
operation CT scan there was no finding of disease in 
other sites of body. The patient was recommended to 
have a close follow up after such surgery. A simple 
cyst of 40 millimeters in the greatest dimension was 
detected in the ultrasonography of her right ovary 
after eight months. Since that cyst was 
asymptomatic and simple, oral contraceptive was 
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prescribed and the patient was also recommended to 
continue close follow up every 2 months. The lesion 
was dwindled and fortunately she was disease free in 
last visit. The time interval between the beginnings 
of follow up is 58 months till writing this report. 
 
Discussion 
Inflammatory myofibroblastic tumor (in past 
also called inflammatory pseudotumor) arises from 
multiple locations. These tumors suggest a chronic 
inflammatory condition [5]. In 1939 First tumor was 
observed in lung and named as IMT by Umiker et al. 
[6] IMT is microscopically characterized by variable 
combinations of proliferating fibroblasts or 
myofibroblasts ,inflammatory cells and eosinophils 
which rarely metastasizes [3, 6-8]. Although it 
doesn’t show a malignant behavior with its low 
proliferation rate but is able to grow by infiltration 
[8]. As half of IMT tumors express anaplastic 
lymphoma kinase (ALK1) protein, 
Immunohistochemistry can be helpful in making a 
correct diagnosis [3, 7]. Several benign fibroblastic 
lesions such as nodular fasciitis, leiomyoma, 
desmoid tumor and myofibroblastosis are in 
differential diagnosis with IMT. ALK expression 
made distinguish of IMT from these conditions 
easier [7, 9]. Various pathogenic backgrounds such 
as infections, neoplastic and autoimmune processes 
have been reported as initiating factors of IMT but 
the exact ethology is still unknown [6]. Infection, 
biliary obstruction, obsesses, primary sclerosing 
cholangitis, primary biliary cirrhosis, LgG4-related 
disease, chron diseases, traumatic origin and 
allergies are suggested as possible causes [5, 10, 11]. 
Morphologic appearance of IMT is consisting of 
spindle cells in a myxoid background with the 
immunprofile of both epithelial and smooth muscle 
markers [12]. These tumors are classified as tumors 
of intermediate biological potential by world health 
organization classification because of tendency for a 
small risk of metastases and local recurrence [13]. 
Rearrangements of the ALK locus on chromosome 
2p23 in 50% of IMTs support the neoplastic nature 
of these lesions [1, 14]. Although ALK presentation 
in IMT is more common in younger people but it’s 
not restricted to this population. Tumor size and 
mitotic activity seems not to have correlation with 
outcomes [1]. Grossly the maximum tumor size is 
up to 12 cm in diameter. Tumor cut surface is tan or 
white and often mucoid. IMT may arise in 
premenopausal women and children [15]. In patient 
with extensive disease and oncogenic ALK 
activation, in case of difficult local control, 
therapeutic ALK inhibition can be helpful [16]. As 
other studies mentioned, IMT of uterus is very rare 
occasion [12, 14, 17-19, 20-23]. 
The previous similar case was a 48 year old 
woman presented with lower abdominal pain and 
hydroureteronephrosis reported by Gucer et al. 
(2005). Rectovaginal examination revealed no uterus 
and adnexal masses. CT scan revealed 5×4cm mass 
in cervix which had envaded both parametria. 
Exploratory laparotomy revealed absence of uteri 
and adnexa. The patient underwent right salpingo-
oophorectomy and subtotal abdominal hysterectomy 
with complete dissection of pelvic lymph nodes as 
well as left nephrectomy [24]. Both parametria and 
Whole cervix were infiltrated by tumor. Tumor 
characterized by proliferation of fibroblastic-like 
spindle cells and defuses infiltration of lymphocyts 
and plasma cells. Immunohistochemical staining 
showed polyclonal infiltration [24]. There was no 
sign of recurrent disease in 8 months follow up [24]. 
In another study Masayuki Shintaku and Akiko 
Fukushima (2006) reported a 63 year old woman 
with complaint of lower abdominal distension [14]. 
Ultrasound and MRI showed a very high intensity 
on T2-weighted image with a few thin septa 
showing a low anterior intensity filling the uterus 
cavity. These septas were enhanced by gadolinium. 
Needle biopsy showed several small tissue 
 
Figure 1. Patients tumor samples and 
immunohistochemistry staining. 3
rd
 image is taken 
from an ALK stained specimen. 
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fragments occupied by atypical spindle on myxoid 
background. As the suggested pathological diagnosis 
was myxoid leiomyosarcoma, total abdominal 
hysterectomy and bilateral salpingooophorectomy 
were done [14]. The patient was free from 
recurrence for 8 months. The tumor was 
approximately 11*6*6cm and was protruded from 
posterior wall into the uterine cavity. More than half 
of this yellowish white tumor showed granular or 
diffuse cytoplasmic immunoreactivity for ALK. 
Tumor cell were arranged in haphazard fashion and 
lace-like or reticular arrangement occasionally [14]. 
 
Conclusion 
Although MIT is one of the rarest tumor, 
because of its nature is  yrev conclusive. Despite of 
controversial treatments methods such as radiation 
therapy or chemotherapy, complete resection is also 
an effective method. Currently this tumor is believed 
to be a low grade tumor in spite of a benign lesion 
that requires low intensity and acceptable prognosis. 
We wish that our experience would be beneficial for 
treatment of such patients. 
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